Controlled Mycobacterium tuberculosis infection in mice under treatment with anti-IL-17A or IL-17F antibodies, in contrast to TNFα neutralization.
about
Yin and yang of interleukin-17 in host immunity to infection.Inhibition of IL-17A by secukinumab shows no evidence of increased Mycobacterium tuberculosis infections.The crucial roles of Th17-related cytokines/signal pathways in M. tuberculosis infection.Interleukin-17 family cytokines in protective immunity against infections: role of hematopoietic cell-derived and non-hematopoietic cell-derived interleukin-17s.GM-CSF targeted immunomodulation affects host response to M. tuberculosis infection.Translational Potential of Therapeutics Targeting Regulatory Myeloid Cells in Tuberculosis
P2860
Controlled Mycobacterium tuberculosis infection in mice under treatment with anti-IL-17A or IL-17F antibodies, in contrast to TNFα neutralization.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Controlled Mycobacterium tuber ...... ntrast to TNFα neutralization.
@en
Controlled Mycobacterium tuber ...... ntrast to TNFα neutralization.
@nl
type
label
Controlled Mycobacterium tuber ...... ntrast to TNFα neutralization.
@en
Controlled Mycobacterium tuber ...... ntrast to TNFα neutralization.
@nl
prefLabel
Controlled Mycobacterium tuber ...... ntrast to TNFα neutralization.
@en
Controlled Mycobacterium tuber ...... ntrast to TNFα neutralization.
@nl
P2093
P2860
P356
P1433
P1476
Controlled Mycobacterium tuber ...... ontrast to TNFα neutralization
@en
P2093
Bernhard Ryffel
Dominique Brees
Elaine Tritto
Franco Di Padova
François Erard
Marie-Laure Bourigault
Michael Kammüller
Muazzam Jacobs
Noria Segueni
Pierre Moulin
P2860
P2888
P356
10.1038/SREP36923
P407
P577
2016-11-17T00:00:00Z